Elk Creek Partners LLC trimmed its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 6.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 179,692 shares of the medical instruments supplier’s stock after selling 12,970 shares during the period. ICU Medical comprises 2.0% of Elk Creek Partners LLC’s investment portfolio, making the stock its 7th biggest holding. Elk Creek Partners LLC owned approximately 0.91% of ICU Medical worth $30,997,000 as of its most recent filing with the SEC.
Other institutional investors also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC raised its stake in shares of ICU Medical by 0.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock valued at $245,000 after acquiring an additional 7 shares during the period. Personal Capital Advisors Corp acquired a new position in shares of ICU Medical in the second quarter valued at approximately $1,494,000. Schwab Charles Investment Management Inc. grew its holdings in shares of ICU Medical by 8.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 62,048 shares of the medical instruments supplier’s stock valued at $9,475,000 after purchasing an additional 4,829 shares in the last quarter. Royce & Associates LP grew its holdings in shares of ICU Medical by 26.7% in the second quarter. Royce & Associates LP now owns 47,400 shares of the medical instruments supplier’s stock valued at $8,177,000 after purchasing an additional 10,000 shares in the last quarter. Finally, KBC Group NV grew its holdings in shares of ICU Medical by 66.0% in the first quarter. KBC Group NV now owns 4,338 shares of the medical instruments supplier’s stock valued at $662,000 after purchasing an additional 1,724 shares in the last quarter. 78.13% of the stock is currently owned by institutional investors and hedge funds.
A number of brokerages recently weighed in on ICUI. Zacks Investment Research upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a report on Monday, September 11th. BidaskClub cut shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 24th. Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. Finally, Sidoti cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $193.00.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://stocknewstimes.com/2017/09/23/icu-medical-inc-icui-is-elk-creek-partners-llcs-7th-largest-position.html.
In other ICU Medical news, VP Virginia Ruth Sanzone sold 1,784 shares of ICU Medical stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $174.47, for a total value of $311,254.48. Following the completion of the transaction, the vice president now owns 102 shares of the company’s stock, valued at $17,795.94. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 463 shares of ICU Medical stock in a transaction on Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the completion of the transaction, the director now directly owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 213,012 shares of company stock valued at $36,438,659. 15.90% of the stock is currently owned by corporate insiders.
Shares of ICU Medical, Inc. (NASDAQ ICUI) traded down 0.22% on Friday, hitting $184.90. 108,581 shares of the stock traded hands. The firm has a market cap of $3.66 billion, a P/E ratio of 74.05 and a beta of 0.36. ICU Medical, Inc. has a 12-month low of $123.77 and a 12-month high of $186.00. The firm’s 50-day moving average is $173.09 and its 200 day moving average is $164.39.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). The company had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The firm’s quarterly revenue was up 242.8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.15 EPS. Equities research analysts forecast that ICU Medical, Inc. will post $4.11 EPS for the current fiscal year.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.